Prediction of severe maternal and perinatal complications in hypertensive pregnancies using point-of-care glycosylated fibronectin: A prospective cohort study

In low-resource settings, GlyFn could serve as a risk-stratification tool for severe maternal and neonatal complications in women presenting with hypertension in low-resource settings.